Related Experiment Video
Updated: May 25, 2026
09:01
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Current and future role of serogenomics in ulcerative colitis
Mark H Flasar1, Raymond K Cross, David B Doman
1Division of Gastroenterology and Hepatology at the University of Maryland School of Medicine, Baltimore, Maryland, USA. mflasar@medicine.umaryland.edu
Gastroenterology & Hepatology
|February 3, 2012
Summary
Serologic and genetic markers show promise for diagnosing and predicting outcomes in ulcerative colitis (UC). While more established in Crohn's disease, these biomarkers can improve clinical decisions for UC patients.
Area of Science:
- Gastroenterology
- Immunology
- Genetics
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- UC arises from inappropriate immune responses in genetically susceptible individuals.
- Serologic and genetic markers are well-established in Crohn's disease (CD) for prognostication but less so for UC.
Purpose of the Study:
- To review the clinical relevance of serologic and genetic markers for UC diagnostics and prognostication.
- To summarize the established and emerging utility of these biomarkers in UC patient management.
Main Methods:
- Literature review of studies using serum and genetic biomarkers in UC.
- Focus on diagnostic, prognostic, and therapeutic response prediction applications.
- Identification and summarization of associated UC biomarkers.
Main Results:
- Several serologic and genetic markers associated with UC were identified.
- The review details the diagnostic and prognostic utility of these markers.
- Biomarker data in UC has potential to enhance clinical decision-making.
Conclusions:
- Serologic and genetic markers offer significant potential for improving UC diagnosis and prognosis.
- Further research and validation are needed to fully integrate these biomarkers into UC clinical practice.
- These biomarkers could lead to more personalized treatment strategies for ulcerative colitis.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:28Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...